Trusted instrument for pharmaceutical research trials. CogScreen results have been used to support drug labeling for more than 30 years.  Exceptional sensitivity to treatment effects.  We provide custom test batteries designed to assess the cognitive outcomes of key importance to your trial.  A reliable instrument with demonstrated sensitivity to a wide range of CNS stimulant and depressive effects.  Unlike competing test batteries, CogScreen has known relationships to the effects of aging,  and is predictive of real-world outcomes.  

• Utilized in Phases 1-4
• Valued for studying efficacy and safety
• Implemented in scientific research programs by NIH, NASA, USAF, USN, US Army, pharmaceutical industry, and by investigators in civilian and military applications across the globe

• Select from among more than 20 validated cognitive tests based on known relationships to neuropharmacology and disease state
• Test instructions provided by video or text
• Practice trials performed to criteria
• Tests administered on reliable tablet PC using touchscreen
• Simultaneously test 20+ participants
• Designed for repeated test administration
• No reliance on cloud-based storage
• Laboratory confirmed 1 msec timing resolution
• Designed to facilitate operations by coordinators, raters, data managers, and biostatistics.

CogScreen has extensive clinical and research experience with the following conditions:

• Depression
• Schizophrenia
• ADHD
• Anxiety
• Multiple Sclerosis
• Alzheimer’s Disease
• Alcohol and Substance Use Disorders
• Age Associated Memory Impairment
• Mild Cognitive Impairment
• Traumatic Brain Injury
• Stroke
• Sleep Disorders; Insomnia & Sleep Apnea